ContraFect Corporation (NASDAQ: CFRX) is -14.65% lower on its value in year-to-date trading and has touched a low of $4.11 and a high of $8.45 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The CFRX stock was last observed hovering at around $4.20 in the last trading session, with the day’s gains setting it 0.11% off its average median price target of $15.00 for the next 12 months. It is also 80.41% off the consensus price target high of $22.00 offered by 5 analysts, but current levels are 33.69% higher than the price target low of $6.50 for the same period.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Currently trading at $4.31, the stock is -15.78% and -19.70% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.05 million and changing 2.62% at the moment leaves the stock -22.06% off its SMA200. CFRX registered -19.44% loss for a year compared to 6-month loss of -18.68%. The firm has a 50-day simple moving average (SMA 50) of $5.2226 and a 200-day simple moving average (SMA200) of $5.3699.
The stock witnessed a -11.68% gain in the last 1 month and extending the period to 3 months gives it a -16.96%, and is -10.21% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.13% over the week and 10.54% over the month.
Distance from 52-week low is 4.87% and -49.02% from its 52-week high.
ContraFect Corporation (CFRX) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for ContraFect Corporation (CFRX) is a “Buy”. 5 analysts offering their recommendations for the stock have an average rating of 2.00, where 0 rate it as a Hold and 1 think it is a “Overweight”. 4 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
ContraFect Corporation is expected to release its quarterly report on 08/12/2021 and quarterly earnings per share for the current quarter are estimated at -$0.2 with sales reaching $3M over the same period.The EPS is expected to grow by 68.80% this year.
ContraFect Corporation (CFRX) Top Institutional Holders
85 institutions hold shares in ContraFect Corporation (CFRX), with 2.2M shares held by insiders accounting for 7.91% while institutional investors hold 50.37% of the company’s shares. The shares outstanding are 27.81M, and float is at 24.68M with Short Float at 13.46%. Institutions hold 46.39% of the Float.
The top institutional shareholder in the company is Federated Hermes, Inc. with over 5.3 million shares valued at $26.75 million. The investor’s holdings represent 13.47% of the CFRX Shares outstanding. As of Dec 30, 2020, the second largest holder is BVF Inc. with 1.6 million shares valued at $8.08 million to account for 4.07% of the shares outstanding. The other top investors are Blackrock Inc. which holds 1.59 million shares representing 4.03% and valued at over $8.01 million, while Vanguard Group, Inc. (The) holds 3.38% of the shares totaling 1.33 million with a market value of $6.71 million.
ContraFect Corporation (CFRX) Insider Activity
A total of 0 insider transactions have happened at ContraFect Corporation (CFRX) in the last six months, with sales accounting for 0 and purchases happening 0 times.
ContraFect Corporation (CFRX): Who are the competitors?
The company’s main competitors (and peers) include Meridian Bioscience Inc. (VIVO) that is trading 196.77% up over the past 12 months and Aldeyra Therapeutics Inc. (ALDX) that is 491.04% higher over the same period. Short interest in the company’s stock has fallen -37.19% from the last report on Mar 14, 2021 to stand at a total of 3.32 million short shares sold with a short interest ratio of 2.34.